Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Kraig Biocraft Laboratories (KBLB) Operating Expenses (2016 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed Operating Expenses for 10 consecutive years, with $513685.0 as the latest value for Q4 2022.

  • Quarterly Operating Expenses fell 0.61% to $513685.0 in Q4 2022 from the year-ago period, while the trailing twelve-month figure was $2.1 million through Dec 2022, down 23.13% year-over-year, with the annual reading at $3.4 million for FY2025, 9.77% up from the prior year.
  • Operating Expenses hit $513685.0 in Q4 2022 for Kraig Biocraft Laboratories, down from $525280.0 in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $1.1 million in Q3 2019 to a low of $288709.0 in Q3 2018.
  • Historically, Operating Expenses has averaged $536438.5 across 4 years, with a median of $516829.0 in 2021.
  • Biggest five-year swings in Operating Expenses: tumbled 74.91% in 2018 and later soared 266.06% in 2019.
  • Year by year, Operating Expenses stood at $432515.0 in 2018, then surged by 144.35% to $1.1 million in 2019, then tumbled by 51.1% to $516829.0 in 2021, then decreased by 0.61% to $513685.0 in 2022.
  • Business Quant data shows Operating Expenses for KBLB at $513685.0 in Q4 2022, $525280.0 in Q3 2022, and $536667.0 in Q2 2022.